Silence Therapeutics plc·4

Jul 23, 2:22 PM ET

Griffiths Richard Ian 4

4 · Silence Therapeutics plc · Filed Jul 23, 2025

Insider Transaction Report

Form 4
Period: 2025-07-21
Transactions
  • Purchase

    American Depositary Shares

    2025-07-21+22,43511,781,093 total(indirect: See footnote)
    Exercise: $6.04Ordinary Shares (67,305 underlying)
  • Purchase

    American Depositary Shares

    2025-07-22+2,91011,784,003 total(indirect: See footnote)
    Exercise: $6.09Ordinary Shares (8,730 underlying)
Footnotes (2)
  • [F1]Each American Depositary Share ("ADS") is immediately convertible into three ordinary shares for no consideration and has no expiration date.
  • [F2]The securities are held by Cream Capital Limited ("Cream"). Mr. Griffiths is a director and the controlling shareholder of Cream. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein.

Documents

1 file
  • 4
    tm2521554-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT